Scribe Therapeutics Inc. - Common Stock (NQ:SCTX)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
61.1% below 52-week high
15.40
13.5052W Low
39.6052W High
1 Week
27.9% below 1-week high
15.121W Low
21.371W High
Scribe Therapeutics Inc. - Common Stock (SCTX) traded between $13.50 and $39.60 over the past 52 weeks and last traded at $15.40, 61.1% below its 52-week high. Over the past week it ranged between $15.12 and $21.37.
Past 12 Months
1W
-$3.99
1M
-$11.13
3M
-$6.24
6M
-$6.24
YTD
-$6.24
1Y
-$6.24
SCTX was -28.8% over the past year, -28.8% over six months, -28.8% year to date, -20.6% in the last week.
12 Months vs Market
SCTX
DIA
SPY
QQQ
IWM
Over the past 12 months SCTX returned -28.8% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
2.30× 3-mo avg
Today 861,605
3-mo avg 375.0K
1W
1M
3M
6M
YTD
1Y
SCTX most recently traded 861,605 shares against a 3-month average daily volume of 375.0K. More NewsRead More
Scribe Therapeutics to Participate in Upcoming Investor Conferences
September 01, 2026
Frequently Asked QuestionsIs Scribe Therapeutics Inc. - Common Stock publicly traded?
Yes, Scribe Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Scribe Therapeutics Inc. - Common Stock trade on?
Scribe Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Scribe Therapeutics Inc. - Common Stock?
The ticker symbol for Scribe Therapeutics Inc. - Common Stock is SCTX on the Nasdaq Stock Market
What is the current price of Scribe Therapeutics Inc. - Common Stock?
The current price of Scribe Therapeutics Inc. - Common Stock is 15.40
When was Scribe Therapeutics Inc. - Common Stock last traded?
The last trade of Scribe Therapeutics Inc. - Common Stock was at 10/23/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||